5-Hydroxytryptophan

Revision as of 01:07, 24 October 2016 by >Unity (Physical effects)

5-Hydroxytryptophan, also known as 5-HTP and oxitriptan, is a naturally occurring amino acid and chemical precursor as well as a metabolic intermediate in the biosynthesis of the neurotransmitters serotonin and melatonin from tryptophan. It is available over the counter in the United States, United Kingdom, and Canada as a dietary supplement and often used as an antidepressant, sleep aid, and appetite suppressant. In some European countries, it is marketed as a prescription drug for the treatment of major depression.[1]

5-Hydroxytryptophan
Chemical Nomenclature
Common names 5-HTP, Oxitriptan, Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum
Substitutive name 5-Hydroxytryptophan
Systematic name 2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid
Class Membership
Psychoactive class Nootropic
Chemical class Tryptamine / Amino acid
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Threshold 25 mg
Light 50 - 100 mg
Common 100 - 300 mg
Strong 300 - 500 mg
Heavy 500 mg +
Duration









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions
SSRIs
SNRIs
Serotonin releasers
MAOIs
Tricyclic antidepressants
Tramadol

5-HTP is also used by users of MDMA and other serotonin-releasing agents to reduce the negative after effects that occur during the drug's come down period, including anxiety, depression, and cognitive fatigue.[2] Since 5-HTP is a precursor for the neurotransmitter serotonin and MDMA depletes serotonin levels in the brain, it is believed that taking 5-HTP after coming down will speed the production of serotonin.

5-HTP should not be taken until 12 hours after the MDMA was last dosed because combining the two drugs could result in a potentially life-threatening condition called serotonin syndrome.

Chemistry

 

This chemistry section is incomplete.

You can help by adding to it.

Pharmacology

The psychoactive action of 5-HTP is derived from its increase in production of serotonin in central nervous system tissue. 5-HTP is decarboxylated to serotonin (5-hydroxytryptamine or 5-HT) by the enzyme aromatic-L-amino-acid decarboxylase with the help of vitamin B6.[3] This reaction occurs both in nervous tissue and in the liver.[4] 5-HTP crosses the blood–brain barrier,[5] while 5-HT does not.

Subjective effects

 
This subjective effects section is a stub.

As such, it is still in progress and may contain incomplete or wrong information.

You can help by expanding or correcting it.

Physical effects

For some individuals, 5-HTP can cause the following side effects (although rare).

Toxicity and harm potential

Due to the conversion of 5-HTP into serotonin by the liver, with prolonged use there may be a significant risk of heart valve disease from serotonin's effect on the heart, which is thought to be due to agonism of the 5HT-2b receptor present on it.[6][7]

It has been suggested that 5-HTP may cause eosinophilia-myalgia syndrome (EMS), a serious condition which results in extreme muscle tenderness, myalgia, and blood abnormalities. However, there is evidence to show that EMS was likely caused by a contaminant in certain 5-HTP supplements instead of the drug itself.[8]

Dangerous interactions

Although many drugs are safe on their own, they can become dangerous and even life-threatening when combined with other substances. The list below contains some common potentially dangerous combinations, but may not include all of them. Certain combinations may be safe in low doses of each but still increase the potential risk of death. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.

Combinations in the list below may increase the amount of neurotransmitters, such as serotonin, to dangerous or even fatal levels, resulting in life-threatening serotonin syndrome.

 

This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

5-HTP is commonly sold over the counter as a health supplement in the United States, United Kingdom, and Canada.

See also

References

  1. https://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA1528&pg=PA773&hl=en#v=onepage&q&f=false | Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
  2. http://www.sciencedirect.com/science/article/pii/S0306452207006732 | Wang, X.; Baumann, M. H.; Dersch, C. M.; Rothman, R. B. (2007-08-10). "Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of l-5-hydroxytryptophan". Neuroscience. 148 (1): 212–220. doi:10.1016/j.neuroscience.2007.05.024. PMID 17629409.
  3. https://www.ncbi.nlm.nih.gov/pubmed/6983619 | Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats.
  4. https://www.ncbi.nlm.nih.gov/pubmed/6974228 | Characteristics of dihydroxyphenylalanine/5-hydroxytryptophan decarboxylase activity in brain and liver of cat.
  5. https://www.ncbi.nlm.nih.gov/pubmed/18445233 | Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat.
  6. https://www.ncbi.nlm.nih.gov/pubmed/15781732 | Long-term serotonin administration induces heart valve disease in rats.
  7. https://www.ncbi.nlm.nih.gov/pubmed/12466135 | Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
  8. https://www.ncbi.nlm.nih.gov/pubmed/7699627 | An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan.
  9. 9.0 9.1 9.2 9.3 https://www.ncbi.nlm.nih.gov/pubmed/18499101 | Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats. Cite error: Invalid <ref> tag; name "one" defined multiple times with different content